News
Dr. Marty Makary, the agency’s commissioner, said too many women avoid hormone therapy because the risks have been overstated ...
US Food and Drug Administration Commissioner Marty Makary said he’s “taking a hard look” at whether a gene therapy from ...
22h
MedPage Today on MSNRemove Boxed Warning on Hormone Therapy for Menopause, FDA Panel SaysA panel selected by FDA Commissioner Marty Makary, MD, MPH, unanimously urged the agency to remove the boxed warning on ...
2d
MedPage Today on MSNA 'Culture Change' Is Needed in Academic Medicine, FDA Commissioner SaysThe culture of academic medicine needs to change, FDA Commissioner Marty Makary, MD, MPH, said at an event sponsored by The ...
1d
NewsNation on MSNFDA chief: HRT warning among ‘greatest mistakes of modern medicine’FDA Commissioner Marty Makary, whose agency convened a panel of experts earlier in the day to discuss the topic, told ...
For decades, proponents of psychedelic drugs have come to Washington with a provocative message: Illegal, mind-altering ...
2d
Agence France-Presse on MSNUS may revise hormone replacement therapy warningsUS Food and Drug Administration Commissioner Marty Makary signaled Thursday that he is open to revising strict warning labels ...
1d
Asianet Newsable on MSNFDA Is Reportedly ‘Taking A Hard Look’ To Evaluate Whether Sarepta’s Gene Therapy Elevidys Should Remain On The MarketThe growing number of fatalities is raising questions about the future of Sarepta’s therapies and the regulatory path for ...
FDA Commissioner Marty Makary's vision for the agency risks the best of an agency that mostly has functioned well for the ...
The Food and Drug Administration plans to ask Sarepta Therapeutics Inc. to pause shipments of its Elevidys treatment after ...
During a press conference on Monday, Food and Drug Administration Commissioner Marty Makary spoke about the agency's ...
According to Makary, reducing user fees—which make up just under half of the FDA's budget—could make it easier for smaller ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results